The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 started the week down around 0.7% at 7,955 points in early afternoon trade.

Australia’s second largest bank Westpac (ASX:WBC) has been down around 1.3% after appointing Anthony Miller as its new CEO. Starting in the role on the 16th of December, Mr Miller is currently CEO of the bank’s Business and Wealth division. He is well regarded internally and amongst external stakeholders, including major shareholders.

Westpac has been trading at $31.68.

All Australian sectors are in the red, weighed down by lower-than-expected Nonfarm Payroll jobs data in the United States.

Discretionary has been down 1.25%, followed closely by Financials 1.2%, and Energy and Telecommunications have both been down around 1%.

Control Bionics (ASX:CBL) has been up around 3.5% after inking a deal to distribute its NeuroNode device distributed throughout the UK and Ireland.

NeuroNode is a wearable device which transfers brain signals to enable speech and other functions. It treats conditions including Motor Neuron Disease and Cerebral Palsy.

Control Bionics has been exchanged at 9 cents.

Core Lithium (ASX:CXO) has been up point six of a percent after making a strategic investment in Charger Metals (ASX:CHR) and the Bynoe Project.

The deal represents around 10% of Charger and is a 30% free carried interest in Charger’s Bynoe Lithium Project from Lithium Australia (ASX:LIT).

Core Lithium has been traded at 8.4 cents.

More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…